Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03059901 · ClinicalTrials.gov registry record · NA

Caminamos: A Smartphone App to Connect With Walking Partners

A NA study, sponsored by Klein Buendel.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT03059901 is a NA study that has completed, run by Klein Buendel. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03059901, a NA study, has completed, sponsored by Klein Buendel.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Despite numerous interventions designed to increase physical activity, few are specifically tailored to Latinas, a population where higher rates of obesity, diabetes, and other chronic diseases are present. This proposed smartphone app will use location-based services to connect Latinas with one another in order to improve walking habits by increasing social support and decreasing perceived barriers, both of which are known to play a role in physical activity behaviors. In this Phase I research, surveys of potential end-users will determine interest in the app and focus groups will help shape a prototype of the app, which will be developed and tested to determine feasibility and functionality for a randomized Phase II intervention.

Interventions

  • OTHER Caminamos App

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2015-08-04
Est. Completion 2016-12-31
Phase NA

Sponsor

Klein Buendel

34 total trials

What the Registry Record Tells You About NCT03059901

The ClinicalTrials.gov registry entry for NCT03059901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Klein Buendel, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Caminamos App is the first listed.

NCT03059901 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03059901 about?

NCT03059901 is a clinical study titled "Caminamos: A Smartphone App to Connect With Walking Partners". Despite numerous interventions designed to increase physical activity, few are specifically tailored to Latinas, a population where higher rates of obesity, diabetes, and other chronic diseases are present. This proposed smartphone app will use location-based services to connect Latinas with one ano...

What is the current status of trial NCT03059901?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-08-04. Estimated completion is 2016-12-31.

What interventions are being tested in trial NCT03059901?

The interventions under investigation include: Caminamos App (OTHER).

Who is sponsoring clinical trial NCT03059901?

This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.